NCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
Clinical Trials
13 trialsNCT07017712 2025-06-12
SeDiGCS
Medizinische Hochschule Brandenburg Theodor Fontane
Completed
NCT05604378 2022-11-03
Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis
Saint Vincent's Hospital, Korea
Completed
NCT04481828 2020-07-22
Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer
Kocaeli Derince Education and Research Hospital
Completed
NCT03061370 2020-03-26
Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer
St. James's Hospital, Ireland
Completed
NCT03071237 2019-02-19
IPA-Origin
Peking University
Completed
NCT03777540 2018-12-17
GCSEP
University of Bologna
Completed
NCT02801955 2017-06-14
Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma
Bezmialem Vakif University
Completed
NCT00147147 2016-09-22
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
Japan Clinical Oncology Group
Phase 3 Completed
NCT00252161 2016-09-22
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Japan Clinical Oncology Group
Phase 3 Completed
NCT02425930 2015-04-24
The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT02048540 2014-04-25
Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell
Chinese PLA General Hospital
Phase 1/2 Completed
NCT01961791 2013-10-11
Lymph Node Staging System With a Novel Concept for Gastric Cancer: a Hybrid Type of Topographic and Numeric Ones
Yonsei University
Completed